The association of apolipoprotein E gene polymorphisms with cerebral palsy in Chinese infants

Yiran Xu1, Honglian Wang, Yanyan Sun

  • 1Department of Pediatrics, the Third Affiliated Hospital of Zhengzhou University, Kangfuqian Street 7, Zhengzhou, 450052, People's Republic of China.

Insights

Genetic variants in the Apolipoprotein E (ApoE) gene are linked to cerebral palsy (CP) risk in the Chinese population. Specific ApoE gene polymorphisms may be a potential risk factor for CP development.

Area of Science:

  • Neuroscience
  • Genetics
  • Pediatrics

Background:

  • Apolipoprotein E (APOE) is a crucial lipid transport protein in brain cells.
  • Previous research suggests a link between Apolipoprotein E (ApoE) gene variants and cerebral palsy (CP) susceptibility.

Purpose of the Study:

  • To investigate the involvement of the ApoE gene in the etiology of cerebral palsy (CP) within the Chinese population.
  • To analyze the association between specific ApoE single nucleotide polymorphisms (SNPs) and CP subtypes.

Main Methods:

  • Genotyping of five Apolipoprotein E (ApoE) single nucleotide polymorphisms (SNPs) in 350 CP patients and 242 healthy controls using the MassARRAY platform.
  • Analysis of genotyping data using the SHEsis program to assess allelic and haplotypic associations with CP.
  • Subgroup analyses were conducted to examine associations with CP subtypes, including preterm birth.

Main Results:

  • A significant difference in allelic frequencies was observed at rs769446 between CP patients and controls (P = 0.005).
  • The rs769446 polymorphism showed significant association with CP in preterm birth cases (P = 0.001).
  • A specific haplotype (rs769446(C), rs405509(C), rs121918399(C), rs429358(T), rs190853081(G)) was associated with a decreased risk of CP (P = 0.002).

Conclusions:

  • Apolipoprotein E (ApoE) gene polymorphisms represent a potential risk factor for cerebral palsy (CP) in the Chinese population.
  • The study provides the first evidence linking specific ApoE gene variants to CP etiology in this demographic.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.2K